Home » Topics » Regulatory

Regulatory
RSS

Hypocholesterolemic activity of raloxifene established in rats

Jan. 28, 1997

Abbott seeks expanded labeling for Norvir

Jan. 24, 1997

Clinical results of gabapentin in ALS reported

Jan. 23, 1997

Raloxifene for inhibition of vascular smooth muscle cell migration

Jan. 23, 1997

Glaxo Wellcome claims new formulation of anxiolytic agent

Jan. 23, 1997

Asta seeks rights to impotency Rx

Jan. 21, 1997

Olopatadine studied for allergic conjunctivitis

Jan. 20, 1997

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

FDA approves topical acne treatment

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...